Authors


Lynn Russo, JD, PhD

Latest:

IP and COVID-19

Disputes over mRNA-related patents are poised to persist.


Luly Dickinson

Latest:

The Global Vaccine R&D Pipeline and Delivery Implications

The current vaccine pipeline brings promise of significant global health advancements—yet development gaps remain, and the future delivery challenges must be considered.



Jeanne Linke Northrop

Latest:

Pushing Boundaries to Revolutionize Chronic Inflammation Therapy

Novel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions.


Anna Pinsky, MD, PhD

Latest:

The EU Regulations Catching US Pharma Companies Off Guard

Companies that understand the regulatory environment in Europe can keep their trials on budget and on schedule.


Jenna Wise

Latest:

Balancing Marketability and Risk in a Drug Name

Navigating the challenging landscape of pharmaceutical naming—where a name must meet regulatory approval, clear trademark hurdles, and capture market attention all at once.


Ariel Katz

Latest:

A Single Source of Truth for KOL Mapping

Coordination of KOL engagement is all but impossible if the information an organization collects about them is fragmented. What is needed is a centralized database that captures all information about an expert from the multiple touch points across functions and geographies.



Greg Killian

Latest:

How Open-Source Benefits Clinical Trials

As therapeutics become more personalized and targeted, technology, such as open-source software, can help companies innovate.


Shemeka Johnson

Latest:

Addressing Health Disparities Through Robust Patient Support Programs

Identifying unique traits in patients is key to creating the most effective support programs.



Bill Barr

Latest:

Reimbursement Benchmark Share: An Objective Measure of the Impact of Product Reimbursement on Sales Performance

Knowing that product reimbursement affects performance and varies by geography, this article proposes the use of Reimbursement Benchmark Share (RBS) to quantify the influence of reimbursement on a product’s performance.



LiveWorld

Latest:

Unlock Social Insights to Drive Pharma Marketing Performance

As the digital and social media revolution continues to evolve, healthcare marketers must consider how to unlock the full potential of social with innovative engagement opportunities.


Pratap Khedkar

Latest:

The Amazon Effect: A Data-Fueled Customer Experience

What the future emergence of Amazon Pharmacy and the company’s aim to own the health experience may mean for pharma manufacturers’ engagement strategies and role in Rx delivery.


Matt Wiley

Latest:

Three Ways to Overcome Any Market Challenge

Pandemic-reinforced principles of successful drug launch.


Dharmendra Sahay

Latest:

Patients Are Ready for a Digital Future, Here’s Pharma’s Path Toward the Next Growth Horizon

Recent advances from COVID-19 vaccine development put pharma in place to further grow relationship with patients.


Alexander Kriz

Latest:

How a “Push and Pull” Approach Can Maximize Innovation Value through HTAs

How can companies adapt their single evidence package at launch into multiple, tailored versions for HTAs that vary across different countries and regions?



Prodeep Bose

Latest:

A Good Time to ‘Revamp’ Sales and Marketing

How one COVID-sparked model could help usher in needed reset.


Jamie Pritchett

Latest:

2022 Prescription Trends

The market for prescription medicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.



Kirsten Axelsen

Latest:

Reducing Prescription Drug Costs for Seniors: The ABCs of ASP for Part D

Outlining the steps to a payment approach for Medicare Part D drugs that provides savings for patients.


Rick Ralston

Latest:

A ‘Sign’ of the Times: Digital Contract Transformation

The pandemic has raised the stakes for companies pursuing new data-harnessing capabilities in contract management and KPI benchmarking and tracking.


Nathan Sheers

Latest:

Key Considerations for Senior Executives Related to Quality Culture

Exploring practical points to further understand and strengthen quality culture.


Krishnan Rajagopalan, PhD

Latest:

Best Practices to Ensure Sourcing and Outsourcing Are Strategic Levers for Competitive Advantage

Optimally designed SSO program can allow companies to deliver therapies to patients faster and at a more affordable cost.


Araz Raoof

Latest:

It’s Time to Invest in Reproductive Medicine and Maternal Health

Amidst lack of funding for women’s health research, industry must collaborate now to advance RMMH.


Guarav Gupta

Latest:

The Learning Advantage: How Strategic L&D Can Optimize Pharma Rotational Programs for Success

Companies offering post-grad rotational programs develop broad skillsets in new hires.


Mike Ward

Latest:

Next-Gen Partnerships: The Ascent of Advanced Therapies

With added push from the COVID-19 pandemic, investment in promising RNA- and cell and gene therapy-based treatments and technology via industry dealmaking is growing considerably.


Tiffany Mura, Dan Berlin and Jen Briselli

Latest:

Leveraging Market Research & User Experience Research in Life Sciences

The right market research insights provide a richer, more-nuanced picture of your customers as people, not just as numbers on a spreadsheet.